FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects during flu season, throw out ASAP
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
PharmiWeb17d
Sea Water Nasal Spray Market: Market Size, Growth, Forecast 2025–2033
According to Business Research Insights the Sea Water Nasal Spray Market expected to exhibit a CAGR of 8.7% by 2033. The "Sea Water Nasal Spray Market" Research is your essential resource for ...
UUHC Health Feed21d
How Does Nasal Rinsing Work and Is It Safe?
Nasal rinsing is safe when you follow the recommended instructions. This means using distilled water (purchased at the store ... Smith suggests using a decongestant spray for no more than three days ...
kalkinemedia21d
Sea Water Nasal Spray Market to Record 8.18% CAGR, Reaching 2.5 Billion USD by 2032 | Dolphin, Neti Pot, Marimer
Sea Water Nasal Spray Market The global sea water nasal spray market is experiencing notable growth driven by an increasing awareness of the benefits associated with natural health US, NY, UNITED STAT ...
Indiatimes22d
FDA approves J&J’s nasal spray for severe depression as stand-alone treatment
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...
India Today22d
US FDA approves new nasal spray for depression treatment: All about it
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
healthday22d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
The Daily Beast22d
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report22d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
Newsweek22d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
New York Post22d
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
Gizmodo23d
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...